News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diamyd Medical AB Release: Quarterly Report I 12/13



1/23/2013 6:13:54 AM

Regulatory News:

Quarterly Report 1, Diamyd Medical AB (publ) (STO:DIAMB)(Pink Sheets:DMYDY), fiscal year 2012/2013

Reporting period September 1, 2012 – November 30, 2012 • Group net sales amounted to MSEK 0 (0.2) • Loss before tax amounted to MSEK -1.8 (-3.5) • Earnings per share after dilution were SEK -0.2 (-0.3) • Liquid assets and short term investments amounted to MSEK 373 (414) as of November 30, 2012

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES